GlassScriptPhysician profile
Shekar P Kumar
NPI 1811978661
$13,822.45
in general payments reported to CMS, 2019-2025
34 companies · $1,452 in 2025
The $1,452 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,492 · 2020: $469 · 2021: $794 · 2022: $1,989 · 2023: $3,327 · 2024: $3,301 · 2025: $1,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,115 · Travel and Lodging: $2,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,115.16 |
| Travel and Lodging | $2,964.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,372.32 | 2019-2025 | Acculink, Diamondback Coronary, Emboshield Nav6 |
| Edwards Lifesciences Corporation | $3,178.93 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $1,086.82 | 2019-2025 | Impella |
| Inari Medical, INC. | $1,076.37 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $978.29 | 2019-2024 | Nrg Rf Transseptal Kit, Eluvia |
| Medtronic, INC. | $507.43 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Medtronic Vascular, INC. | $279.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $250.63 | 2019-2024 | |
| Atricure, INC. | $201.09 | 2019-2023 | |
| Cardiovascular Systems INC. | $175.26 | 2019-2022 | |
| Stryker Corporation | $170.23 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.61 | 2019-2025 | Lifevest |
| Acist Medical Systems, INC. | $162.25 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $160.07 | 2019-2025 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $151.43 | 2019-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $132.86 | 2019-2024 | Repatha |
| Shockwave Medical, INC | $99.62 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Vital Connect, INC | $91.87 | 2022 | |
| Sanofi-Aventis U.S. LLC | $79.16 | 2019 | |
| Angiodynamics, INC. | $74.85 | 2024-2025 | Alphavac |
| Philips North America LLC | $71.55 | 2020-2025 | (Cm9) Amb Mon & Diag Und, Azurion 7 M20 |
| Cvrx, INC. | $57.45 | 2023-2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.65 | 2019-2022 | |
| Penumbra, INC. | $39.96 | 2024 | Penumbra System, Indigo System |
| Biosense Webster, INC. | $36.01 | 2021 | |
| Recor Medical INC | $25.48 | 2024 | Paradise Renal Denervation System |
| Merck Sharp & Dohme LLC | $23.11 | 2023 | Verquvo |
| Alnylam Pharmaceuticals INC. | $22.74 | 2023 | Onpattro |
| Portola Pharmaceuticals, LLC | $21.51 | 2019 | |
| Cardiva Medical, INC. | $19.08 | 2024 | Optowire |
| Glaxosmithkline, LLC. | $18.37 | 2023 | Shingrix |
| Janssen Pharmaceuticals, INC | $17.27 | 2023 | Xarelto |
| Pfizer INC. | $13.38 | 2021 | |
| Thrombolex, INC. | $13.11 | 2024 | Bashir Endovascular Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shekar Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.